What Happened When Patients With Cancer Took Psilocybin at MD Anderson?

In the third episode of Clinical Trial Corner, Dr. Moran Amit of The University of Texas MD Anderson Cancer Center discusses how psilocybin-assisted psychotherapy is being studied for patients with cancer, particularly those living long-term with cancer during maintenance therapy. In this interview with CURE, Amit explains the difference between recreational psychedelic use and controlled clinical treatment, the role of cancer neuroscience and why mental health support should be a core part of oncology care. Full article: https://www.curetoday.com/view/clinic... For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here. View more at http://curetoday.com/ Or visit our socials!   / cure_today     / curetoday     / curemagazine     / cure-media-group     / cure_today